Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
Aspartic acid is an amino acid commonly found as a component in total parenteral nutrition. One of the non-essential amino acids commonly occurring in the L-form.
- Mechanism
- Curator reviewed
There are also claims that L-aspartate has ergogenic effects, that it enhances performance in both prolonged exercise and short intensive exercise. It is hypothesized that L-aspartate, especially the potassium magnesium aspartate salt, spares stores of muscle glycogen and/or promotes a faster rate of glycogen resynthesis during exercise. It has also been hypothesized that L-aspartate can enhance short intensive exercise by serving as a substrate for energy production in the Krebs cycle and for stimulating the purine nucleotide cycle.
- Primary indication
- There is no support for the claim that aspartates are exercise performance enhancers, i.e. ergogenic aids.Curator reviewed · 1 structured indication
- Formula / weight
- C4H7NO4 · 133.1027 g/mol (avg)
- First approval
- Canada, 1999 · United States, 1984
- Also known as
- 2-Aminosuccinic acid · L-Asp · L-Aspartate · L-Aspartic acid
- Code names
- FEMA NO. 3656
- Brand names
- Aminosyn II 7 %, Sulfite-free
- Aminosyn-PF 7%
- Clinisol 15
- Olimel
- Periolimel
- Plenamine
- Premasol
- Primene
- Prosol
- Trophamine 10 %
Resolves to
CKLJMWTZIZZHCS-REOHCLBHSA-NSMILESN[C@@H](CC(O)=O)C(O)=OWhat you can answer from here — as of September 23, 2026
Which drugs share a target with Aspartic acid, and which of those have an active Phase 3 trial?